BRAF and glioblastoma: A variety of genetic, imaging, and histopathological markers are used as diagnostic biomarkers in juvenile glioblastoma. These encompass protein biomarkers, magnetic resonance imaging (MRI), MRS, DNA methylation patterns, and BRAF V600E mutations. When these indicators are combined, a thorough and precise diagnosis may be made, which helps doctors create specialized treatment plans for young glioblastoma patients.